Transcode Therapeutics Correlations

RNAZ Stock

USD 9.69 0.25 2.52%

The current 90-days correlation between Transcode Therapeutics and Ensysce Biosciences is 0.03 (i.e., Significant diversification). The correlation of Transcode Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Transcode Therapeutics Correlation With Market

Average diversification

The correlation between Transcode Therapeutics and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Transcode Stock

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Transcode Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Transcode Stock please use our How to Invest in Transcode Therapeutics guide.

Moving against Transcode Stock

0.46	KB	KB Financial Group	Pair Corr
0.37	CGEN	Compugen	Pair Corr
0.36	AVAL	Grupo Aval	Pair Corr
0.34	SHG	Shinhan Financial Earnings Call This Week	Pair Corr
0.31	RCUS	Arcus Biosciences	Pair Corr
0.55	DIS	Walt Disney	Pair Corr
0.51	IBM	International Business Earnings Call Tomorrow	Pair Corr
0.45	CSCO	Cisco Systems	Pair Corr
0.42	AA	Alcoa Corp	Pair Corr
0.41	TRV	The Travelers Companies	Pair Corr
0.39	MSFT	Microsoft Aggressive Push	Pair Corr
0.38	AXP	American Express	Pair Corr
0.33	PG	Procter Gamble Earnings Call This Week	Pair Corr

Related Correlations Analysis

	RVPH	ZVSA	UNCY	ENSC	DRMA	MTVA	PALI
RVPH		0.1	0.54	0.22	0.54	0.55	-0.01	RVPH
ZVSA	0.1		0.36	0.1	-0.1	0.19	-0.47	ZVSA
UNCY	0.54	0.36		0.19	0.17	0.19	-0.32	UNCY
ENSC	0.22	0.1	0.19		0.27	0.44	0.18	ENSC
DRMA	0.54	-0.1	0.17	0.27		0.49	0.26	DRMA
MTVA	0.55	0.19	0.19	0.44	0.49		0.14	MTVA
PALI	-0.01	-0.47	-0.32	0.18	0.26	0.14		PALI
	RVPH	ZVSA	UNCY	ENSC	DRMA	MTVA	PALI

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MTVA	+ 0.55	RVPH
UNCY	+ 0.54	RVPH
DRMA	+ 0.54	RVPH
MTVA	+ 0.49	DRMA
MTVA	+ 0.44	ENSC
UNCY	+ 0.36	ZVSA

High negative correlations

PALI	- 0.47	ZVSA
PALI	- 0.32	UNCY
DRMA	- 0.1	ZVSA
PALI	- 0.01	RVPH

Risk-Adjusted Indicators

There is a big difference between Transcode Stock performing well and Transcode Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Transcode Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RVPH	5.73	(0.19)	0.00	0.23	0.00	0.00	11.76	(9.28)	69.49
ZVSA	6.32	(2.15)	0.00	(3.93)	0.00	0.00	9.38	(17.95)	67.27
UNCY	5.46	(0.11)	(0.01)	0.02	10.05	(5.50)	14.48	(10.52)	60.25
ENSC	5.76	0.00	0.06	0.14	6.37	(6.68)	9.35	(12.15)	109.72
DRMA	3.27	(0.20)	0.00	(0.13)	0.00	0.00	8.47	(6.90)	22.00
MTVA	3.35	(0.15)	0.00	32.07	0.00	0.00	7.81	(7.35)	35.49
PALI	3.65	0.62	0.12	2.53	3.47	(5.12)	7.25	(5.63)	18.72

Transcode Therapeutics Corporate Management

RN MBA	Senior Operations	Profile
Daniel MD	Chief Officer	Profile
Anna Moore	Scientific CoFounder	Profile
Calais Pharm	Executive Board	Profile
Robert Dudley	CEO, CoFounder	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC